Simvastatin Enhances Stem Cell Osteogenesis and Reduces Peri-Implant Bone Loss: An In Vitro and a Randomized Clinical...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Dental Implantology

Background:

• Preclinical data suggest statins promote osteogenesis, but clinical evidence for statin-incorporated platelet-rich fibrin (SIM-PRF) in preventing peri-implant bone loss is limited.
• Platelet-rich fibrin (PRF) is widely used clinically, yet its combination with statins (SIM-PRF) requires further validation for efficacy in limiting crestal bone loss around dental implants.

Purpose of the Study:

• To evaluate the clinical effectiveness of SIM-PRF in reducing early and 12-month marginal bone loss compared to PRF alone and PRF with bone graft.
• To assess the in vitro effects of SIM on human periodontal ligament stem cells (hPDLSCs), including cytotoxicity, migration, osteogenic differentiation, and inflammatory markers.

Main Methods:

• In vitro studies involved assessing hPDLSC viability, migration, osteogenic differentiation (mineralization, alkaline phosphatase, gene expression), and inflammatory cytokine release (TNF-α, IL-6) following SIM treatment.
• A controlled clinical trial randomized 24 immediate-implant cases into three groups: PRF, PRF+SIM, or PRF+bone graft.
• Crestal bone changes were measured using cone-beam computed tomography (CBCT) at 0-3, 3-6, and 6-12 months post-surgery.

Main Results:

• Low concentrations of SIM (0.1 μM) enhanced hPDLSC osteogenic differentiation and mineralization without affecting cell viability or migration, while reducing pro-inflammatory cytokines (TNF-α, IL-6).
• Radiographic analysis showed significantly reduced crestal bone loss in the PRF-SIM and PRF-Bone groups compared to PRF alone (p < 0.001), especially in early healing phases (0-3 and 3-6 months).
• No significant difference in peri-implant bone preservation was found between the PRF-SIM and PRF-Bone groups (p > 0.05).

Conclusions:

• SIM-loaded PRF demonstrates potential as a biocompatible and patient-friendly biomaterial for enhancing bone regeneration around dental implants.
• SIM-PRF effectively reduces early marginal bone loss, comparable to traditional bone grafts, suggesting improved dental implant success rates.
• Further clinical studies can validate SIM-PRF as a promising adjunct in implant dentistry for bone preservation and regeneration.